Samsung Discontinues Vascular Load Feature on US Galaxy Watches

WHO:

TechRadar - Samsung, a South Korean firm, is involved in the discontinuation of the Vascular Load feature.

SamMobile - Samsung is expected to launch the Galaxy Watch 9 and Galaxy Watch Ultra 2.

WHAT:

TechRadar - Samsung is discontinuing the Vascular Load tracking tool on Galaxy Watches in the US.

SamMobile - The Vascular Load feature, which was in beta, is being removed from Galaxy Watches in the US.

SamMobile - Samsung is introducing a new feature called Blood Pressure Trend with the upcoming Galaxy Watch 9 and Galaxy Watch Ultra 2.

WHERE:

TechRadar - The Vascular Load feature is being removed specifically in the US.

SamMobile - The feature will still be available for users in other countries.

WHEN:

SamMobile - Samsung is expected to launch the Galaxy Watch 9 and Galaxy Watch Ultra 2 later this month.

WHY:

SamMobile - The removal of the Vascular Load feature in the US may be related to regulatory requirements from the U.S. Food and Drug Administration (FDA), although Samsung has not provided an official reason.

HOW:

SamMobile - The Vascular Load feature monitors stress on the vascular system using data from a compatible Galaxy Watch’s heart rate sensor over at least seven days to analyze photoplethysmogram (PPG) waveforms.

(UPDATED July 2, 2026 19:30 UTC)

Samsung is discontinuing the Vascular Load tracking tool on Galaxy Watches in the U.S., which was still in beta, while users in other countries will continue to have access to it. This change may be linked to regulatory requirements from the U.S. Food and Drug Administration, although Samsung has not confirmed the reason for the removal. Meanwhile, the company is set to launch the Galaxy Watch 9 and Galaxy Watch Ultra 2 later this month, introducing a new feature called Blood Pressure Trend.